Guidance

Post-licensure vaccine services

VDEC provides a number of services for vaccines post-licensure

From:
UK Health Security Agency
Published
20 May 2024
Last updated
16 July 2024 — See all updates

The Vaccine Development and Evaluation Centre (VDEC) supports scientists at every stage of the vaccine and therapeutic medicine development process including in the post-licensure phase.

Work with VDEC

We work with industry, academia and government. Contact UKHSA today to see how we can help you.

Get in touch

What we can offer

VDEC currently supports the UK’s annual influenza vaccine batch release by offering a range of compliant studies, including to good laboratory practice (GLP) or good manufacturing practice (GMP) as appropriate. These include:

  • phase IV study support, including immunogenicity and antisera studies
  • sero and molecular surveillance
  • support batch release testing for licensed vaccines
  • the development of potency tests to support vaccine release plus release of developmental vaccines
  • stability studies

Equipment at our Porton Down laboratory

The post-licensure phase ensures that vaccines continue to be safe and effective.

Updates to this page

Published 20 May 2024
Last updated 16 July 2024 + show all updates

  1. Added the VDEC form link.

  2. First published.

Sign up for emails or print this page

Contents

Related content